Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
PHILADELPHIA, May 02, 2023 -- Cabaletta Bio, Inc. , a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with... | May 2, 2023